Patents Assigned to HS Pharmaceuticals, LLC
  • Patent number: 11351191
    Abstract: The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair.
    Type: Grant
    Filed: October 31, 2019
    Date of Patent: June 7, 2022
    Assignee: HS PHARMACEUTICALS, LLC
    Inventors: Richard Thomas Stanley, Sr., David Edward Stanley, Marcus Blackstone, Thomas Wagner
  • Patent number: 10493097
    Abstract: The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair.
    Type: Grant
    Filed: December 28, 2017
    Date of Patent: December 3, 2019
    Assignee: HS PHARMACEUTICALS, LLC
    Inventors: Richard Thomas Stanley, Sr., David Edward Stanley, Marcus Blackstone, Thomas Wagner
  • Patent number: 9889151
    Abstract: The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: February 13, 2018
    Assignee: HS PHARMACEUTICALS, LLC
    Inventors: Richard Thomas Stanley, Sr., David Edward Stanley, Marcus Blackstone, Thomas Wagner
  • Patent number: 9333224
    Abstract: The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair.
    Type: Grant
    Filed: February 4, 2013
    Date of Patent: May 10, 2016
    Assignee: HS PHARMACEUTICALS, LLC
    Inventors: Richard Thomas Stanley, Sr., David Edward Stanley, Marcus Blackstone, Thomas Wagner
  • Publication number: 20130149396
    Abstract: The present invention relates to compositions comprising a silicate and methods of use thereof. In particular, the compositions of the present invention are suitable for treating inflammatory conditions, cancer, bacterial and viral infections, and infected and uninfected wounds. The compositions of the present invention can also be useful in treating spinal cord injury, tissue remodeling, and promoting bone growth and repair.
    Type: Application
    Filed: February 4, 2013
    Publication date: June 13, 2013
    Applicant: HS Pharmaceuticals, LLC
    Inventor: HS Pharmaceuticals, LLC